These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Serotonin transporter availability in thalamic subregions in schizophrenia: a study using 7.0-T MRI with [(11)C]DASB high-resolution PET. Kim JH, Son YD, Kim JH, Choi EJ, Lee SY, Lee JE, Cho ZH, Kim YB. Psychiatry Res; 2015 Jan 30; 231(1):50-7. PubMed ID: 25465315 [Abstract] [Full Text] [Related]
4. The new PET imaging agent [11C]AFE is a selective serotonin transporter ligand with fast brain uptake kinetics. Zhu Z, Guo N, Narendran R, Erritzoe D, Ekelund J, Hwang DR, Bae SA, Laruelle M, Huang Y. Nucl Med Biol; 2004 Nov 30; 31(8):983-94. PubMed ID: 15607480 [Abstract] [Full Text] [Related]
6. Comparative evaluation in nonhuman primates of five PET radiotracers for imaging the serotonin transporters: [11C]McN 5652, [11C]ADAM, [11C]DASB, [11C]DAPA, and [11C]AFM. Huang Y, Hwang DR, Narendran R, Sudo Y, Chatterjee R, Bae SA, Mawlawi O, Kegeles LS, Wilson AA, Kung HF, Laruelle M. J Cereb Blood Flow Metab; 2002 Nov 30; 22(11):1377-98. PubMed ID: 12439295 [Abstract] [Full Text] [Related]
7. Comparative evaluation of serotonin transporter radioligands 11C-DASB and 11C-McN 5652 in healthy humans. Frankle WG, Huang Y, Hwang DR, Talbot PS, Slifstein M, Van Heertum R, Abi-Dargham A, Laruelle M. J Nucl Med; 2004 Apr 30; 45(4):682-94. PubMed ID: 15073266 [Abstract] [Full Text] [Related]
9. Effects of reduced endogenous 5-HT on the in vivo binding of the serotonin transporter radioligand 11C-DASB in healthy humans. Talbot PS, Frankle WG, Hwang DR, Huang Y, Suckow RF, Slifstein M, Abi-Dargham A, Laruelle M. Synapse; 2005 Mar 01; 55(3):164-75. PubMed ID: 15605360 [Abstract] [Full Text] [Related]
11. Effects of tryptophan depletion on the binding of [11C]-DASB to the serotonin transporter in baboons: response to acute serotonin deficiency. Milak MS, Ogden RT, Vinocur DN, Van Heertum RL, Cooper TB, Mann JJ, Parsey RV. Biol Psychiatry; 2005 Jan 01; 57(1):102-6. PubMed ID: 15607307 [Abstract] [Full Text] [Related]
13. Synthesis and pharmacological characterization of a new PET ligand for the serotonin transporter: [11C]5-bromo-2-[2-(dimethylaminomethylphenylsulfanyl)]phenylamine ([11C]DAPA). Huang Y, Hwang DR, Zhu Z, Bae SA, Guo N, Sudo Y, Kegeles LS, Laruelle M. Nucl Med Biol; 2002 Oct 01; 29(7):741-51. PubMed ID: 12381454 [Abstract] [Full Text] [Related]
18. Estimation of serotonin transporter parameters with 11C-DASB in healthy humans: reproducibility and comparison of methods. Frankle WG, Slifstein M, Gunn RN, Huang Y, Hwang DR, Darr EA, Narendran R, Abi-Dargham A, Laruelle M. J Nucl Med; 2006 May 01; 47(5):815-26. PubMed ID: 16644752 [Abstract] [Full Text] [Related]
19. Biodistribution and radiation dosimetry of the serotonin transporter ligand 11C-DASB determined from human whole-body PET. Lu JQ, Ichise M, Liow JS, Ghose S, Vines D, Innis RB. J Nucl Med; 2004 Sep 01; 45(9):1555-9. PubMed ID: 15347724 [Abstract] [Full Text] [Related]
20. Comparison of (+)-(11)C-McN5652 and (11)C-DASB as serotonin transporter radioligands under various experimental conditions. Szabo Z, McCann UD, Wilson AA, Scheffel U, Owonikoko T, Mathews WB, Ravert HT, Hilton J, Dannals RF, Ricaurte GA. J Nucl Med; 2002 May 01; 43(5):678-92. PubMed ID: 11994534 [Abstract] [Full Text] [Related] Page: [Next] [New Search]